Home › Funds › PERCEPTIVE ADVISORS LLC › CTMX
PERCEPTIVE ADVISORS LLC position in CTMX
CYTOMX THERAPEUTICS INC. · Health Care
PERCEPTIVE ADVISORS LLC reported holding 10,439,185 shares of CTMX (CYTOMX THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$39.1M, representing 0.62% of its reported portfolio and ranking #37 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed CTMX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's CTMX position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in CTMX in Q2 2025 at 6,993,646 shares (US$15.9M). The position peaked in Q1 2026 at 10,098,824 shares, worth US$47.5M. Across 5 filings, PERCEPTIVE ADVISORS LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 10,439,185 shares valued at US$39.1M — an increase of 340,361 shares quarter over quarter.. Notable position changes include a 38% increase in Q3 2025 (shares rose 34% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 6.99M | $15.88M | New |
| Q3 2025 | 9.68M | $30.88M | Add |
| Q4 2025 | 9.68M | $41.24M | Hold |
| Q1 2026 | 10.10M | $47.46M | Add |
| Q2 2026 | 10.44M | $39.15M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CTMX and 13F data
CTMX (CYTOMX THERAPEUTICS INC.) is a Health Care company. 45 other funds we track also report a position in CTMX — the largest reported positions include Kynam Capital Management, LP (US$81.4M), Venrock Adviser, LLC (US$18.7M), Elmind Capital, LP (US$17.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CTMX
- Kynam Capital Management, LP 21.70M sh · $81.39M · Q2 2026
- Venrock Adviser, LLC 4.98M sh · $18.68M · Q2 2026
- Elmind Capital, LP 4.55M sh · $17.06M · Q2 2026
- Nextech Invest Ltd. 4.45M sh · $16.69M · Q2 2026
- Eversept Partners, LP 3.56M sh · $13.34M · Q2 2026
- ADAR1 Capital Management, LLC 3.37M sh · $12.62M · Q2 2026
- Seven Fleet Capital Management LP 1.09M sh · $4.07M · Q2 2026
- Ally Bridge Group (NY) LLC 775.00K sh · $2.91M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held CTMX?
PERCEPTIVE ADVISORS LLC has disclosed CTMX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is PERCEPTIVE ADVISORS LLC's current position in CTMX?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 10.44M shares of CTMX (CYTOMX THERAPEUTICS INC.), valued at $39.15M, representing 0.62% of its reported portfolio and ranking #37.
Has PERCEPTIVE ADVISORS LLC been buying or selling CTMX?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in CTMX. The position peaked in Q1 2026 at 10.10M shares.
Which other funds hold CTMX?
Other major institutional holders of CTMX include Kynam Capital Management, LP, Venrock Adviser, LLC, Elmind Capital, LP, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.